Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Smith

Showing results (411-420 of 443) with videos related to

Pageof 45
Sort By:
Bioorganic & Medicinal Chemistry Letters|April 9, 2013
Arylsulfonamide pyrimidines as VLA-4 antagonistsYing-Zi Xu, Andrei W Konradi, Frederique Bard, et al.
Breast Cancer Research and Treatment|June 6, 2019
Neuronatin is a modifier of estrogen receptor-positive breast cancer incidence and outcomeCody Plasterer, Shirng-Wern Tsaih, Amy R Peck, et al.
MMWR Supplements|August 21, 2020
Overview and Methods for the Youth Risk Behavior Surveillance System - United States, 2019J Michael Underwood, Nancy Brener, Jemekia Thornton, et al.
MMWR Supplements|October 8, 2024
Overview and Methods for the Youth Risk Behavior Surveillance System - United States, 2023Nancy D Brener, Jonetta J Mpofu, Kathleen H Krause, et al.
The New England Journal of Medicine|May 2, 2017
Trial of Transplantation of HCV-Infected Kidneys into Uninfected RecipientsDavid S Goldberg, Peter L Abt, Emily A Blumberg, et al.
Molecular Cancer Therapeutics|December 2, 2022
Discovery of STRO-002, a Novel Homogeneous ADC Targeting Folate Receptor Alpha, for the Treatment of Ovarian and Endometrial CancersXiaofan Li, Sihong Zhou, Cristina L Abrahams, et al.
MMWR Supplements|April 27, 2023
Overview and Methods for the Youth Risk Behavior Surveillance System - United States, 2021Jonetta J Mpofu, J Michael Underwood, Jemekia E Thornton, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 26, 2015
Selective Targeting of a Disease-Related Conformational Isoform of Macrophage Migration Inhibitory Factor Ameliorates Inflammatory ConditionsMichael Thiele, Randolf J Kerschbaumer, Frederick W K Tam, et al.
Annals of Internal Medicine|August 8, 2018
Twelve-Month Outcomes After Transplant of Hepatitis C-Infected Kidneys Into Uninfected Recipients: A Single-Group TrialPeter P Reese, Peter L Abt, Emily A Blumberg, et al.
Nature|February 17, 2006
Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humansTimothy J Aitman, Rong Dong, Timothy J Vyse, et al.
Pageof 45

Showing results (411-420 of 443) with videos related to

Sort By:
Pageof 45
Bioorganic & Medicinal Chemistry Letters|April 9, 2013
Arylsulfonamide pyrimidines as VLA-4 antagonistsYing-Zi Xu, Andrei W Konradi, Frederique Bard, et al.
Breast Cancer Research and Treatment|June 6, 2019
Neuronatin is a modifier of estrogen receptor-positive breast cancer incidence and outcomeCody Plasterer, Shirng-Wern Tsaih, Amy R Peck, et al.
MMWR Supplements|August 21, 2020
Overview and Methods for the Youth Risk Behavior Surveillance System - United States, 2019J Michael Underwood, Nancy Brener, Jemekia Thornton, et al.
MMWR Supplements|October 8, 2024
Overview and Methods for the Youth Risk Behavior Surveillance System - United States, 2023Nancy D Brener, Jonetta J Mpofu, Kathleen H Krause, et al.
The New England Journal of Medicine|May 2, 2017
Trial of Transplantation of HCV-Infected Kidneys into Uninfected RecipientsDavid S Goldberg, Peter L Abt, Emily A Blumberg, et al.
Molecular Cancer Therapeutics|December 2, 2022
Discovery of STRO-002, a Novel Homogeneous ADC Targeting Folate Receptor Alpha, for the Treatment of Ovarian and Endometrial CancersXiaofan Li, Sihong Zhou, Cristina L Abrahams, et al.
MMWR Supplements|April 27, 2023
Overview and Methods for the Youth Risk Behavior Surveillance System - United States, 2021Jonetta J Mpofu, J Michael Underwood, Jemekia E Thornton, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 26, 2015
Selective Targeting of a Disease-Related Conformational Isoform of Macrophage Migration Inhibitory Factor Ameliorates Inflammatory ConditionsMichael Thiele, Randolf J Kerschbaumer, Frederick W K Tam, et al.
Annals of Internal Medicine|August 8, 2018
Twelve-Month Outcomes After Transplant of Hepatitis C-Infected Kidneys Into Uninfected Recipients: A Single-Group TrialPeter P Reese, Peter L Abt, Emily A Blumberg, et al.
Nature|February 17, 2006
Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humansTimothy J Aitman, Rong Dong, Timothy J Vyse, et al.
Pageof 45